Loading...
4CPS-152 Eculizumab for dense deposit disease: increased dosage without response: a case report
BACKGROUND: Dense deposit disease (DDD) is a rare glomerulonephritis caused by uncontrolled stimulation of the alternative complement pathway. Allograft survival after kidney transplantation is significantly reduced by the high rate of disease recurrence. No therapeutic interventions have consistent...
Na minha lista:
| Udgivet i: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Group
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535363/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.243 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|